COR-1167

DRUG2 trials

Sponsors

Corteria Pharmaceuticals

Conditions

Worsening Heart Failure

Phase 2

CRF2 Agonist for the Treatment of Worsening Heart Failure

SuspendedNCT06815471

Corteria PharmaceuticalsWorsening Heart Failure

Start: 2025-08-07End: 2026-12-01Target: 300Updated: 2026-07-22

Corticotrophin Releasing Factor 2 Agonist For the Treatment of Worsening Heart Failure (WHF) – The CRAFT-WHF Study

RecruitingCTIS2024-518951-52-00

Corteria PharmaceuticalsWorsening Heart Failure

Start: 2025-11-12Target: 170Updated: 2025-10-28